Basics Candel Therapeutics, Inc. Common Stock IPO Date: July 27, 2021 Sector: Healthcare Industry: Biotech Market Cap: $274.48M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 4.99% Avg Daily Range (30 D): $0.14 | 2.31% Avg Daily Range (90 D): $0.17 | 2.96% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .79M Trade Size Avg Trade Size (Sh.): 150 Avg Trade Size (Sh.) (30 D): 125 Avg Trade Size (Sh.) (90 D): 135 Institutional Trades Total Inst.Trades: 105 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.31M Avg Inst. Trade (90 D): $1.56M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.15M Avg Closing Trade (30 D): $5.25M Avg Closing Trade (90 D): $3.16M Avg Closing Volume: 311.83K     News Apr 1, 2025 @ 12:01 PM Candel Therapeutics Announces Publication of Phase... Source: N/A Mar 18, 2025 @ 12:00 PM Candel Therapeutics Appoints Renowned Pancreatic C... Source: N/A Dec 12, 2024 @ 9:51 PM Candel Therapeutics Announces $80 Million Proposed... Source: N/A Sep 4, 2024 @ 12:00 PM Milestone Pharmaceuticals Appoints Industry Vetera... Source: N/A Jul 19, 2024 @ 12:41 PM Candel Therapeutics executive sells over $63k in c... Source: Investing.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.09 $.15 Diluted EPS $-.09 $.13 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -4.8M $ 7.38M Operating Income / Loss $ $ -11.18M $ -8.13M Cost of Revenue $ $ $ Net Cash Flow $ $ 8.52M $ -10.49M PE Ratio